UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 103

Sortiert nach

British Association of Dermatologists' guidelines for biologic interventions for psoriasis 2009

British journal of dermatology (1951), 2009-11, Vol.161 (5), p.987-1019

2009

Link zum Volltext

Verfügbarkeit prüfen

A classification of psoriasis vulgaris according to phenotype

British journal of dermatology (1951), 2007-02, Vol.156 (2), p.258-262

2007

Link zum Volltext

Verfügbarkeit prüfen

Infliximab for severe, treatment-resistant psoriasis: a prospective, open-label study

British journal of dermatology (1951), 2006-07, Vol.155 (1), p.160-169

2006

Link zum Volltext

Verfügbarkeit prüfen

The development of sarcoidosis on antitumour necrosis factor therapy: a paradox

British journal of dermatology (1951), 2010-09, Vol.163 (3), p.648-649

2010

Link zum Volltext

Verfügbarkeit prüfen

Methotrexate or fumarates: which is the best oral treatment for psoriasis?: Commentaries

British journal of dermatology (1951), 2011-04, Vol.164 (4), p.695-695

Barker, J.N.W.N.

2011

Link zum Volltext

Verfügbarkeit prüfen

Screening for anxiety and depression in people with psoriasis: a cross‐sectional study in a tertiary referral setting

British journal of dermatology (1951), 2017-04, Vol.176 (4), p.1028-1034

2017

Link zum Volltext

Verfügbarkeit prüfen

The quest for psoriasis susceptibility genes in the postgenome-wide association studies era: charting the road ahead: Psoriasis genetics in the post-GWAS era

British journal of dermatology (1951), 2012-06, Vol.166 (6), p.1173-1175

2012

Link zum Volltext

Verfügbarkeit prüfen

Localization of endothelial proliferation and microvascular expansion in active plaque psoriasis

British journal of dermatology (1951), 1997-06, Vol.136 (6), p.859-865

1997

Link zum Volltext

Verfügbarkeit prüfen

Demographics and disease characteristics of patients with psoriasis enrolled in the British Association of Dermatologists Biologic Interventions Register

British journal of dermatology (1951), 2015-08, Vol.173 (2), p.510-518

2015

Link zum Volltext

Verfügbarkeit prüfen

A standardization approach to compare treatment safety and effectiveness outcomes between clinical trials and real‐world populations in psoriasis

British journal of dermatology (1951), 2019-12, Vol.181 (6), p.1265-1271

2019

Link zum Volltext

Verfügbarkeit prüfen

Antinuclear antibodies associate with loss of response to antitumour necrosis factor-α therapy in psoriasis: a retrospective, observational study

British journal of dermatology (1951), 2010-04, Vol.162 (4), p.780-785

2010

Link zum Volltext

Verfügbarkeit prüfen

The quest for psoriasis susceptibility genes in the postgenome-wide association studies era: charting the road ahead

British Journal of Dermatology, 2012-06, Vol.166 (6), p.1173-1175

2012

Link zum Volltext

Verfügbarkeit prüfen

Systemic antipsoriatic therapy may reverse endothelial dysfunction: reply from authors: Correspondence

British journal of dermatology (1951), 2011-06, Vol.164 (6), p.1398-1398

2011

Link zum Volltext

Verfügbarkeit prüfen

Risks of basal cell and squamous cell carcinoma in psoriasis patients after treatment with biologic vs non‐biologic systemic therapies

Journal of the European Academy of Dermatology and Venereology, 2021-08, Vol.35 (8), p.e496-e498

2021

Link zum Volltext

Verfügbarkeit prüfen

Characteristics and skin cancer risk of psoriasis patients with a history of skin cancer in BADBIR

Journal of the European Academy of Dermatology and Venereology, 2021-08, Vol.35 (8), p.e498-e501

2021

Link zum Volltext

Verfügbarkeit prüfen

Clinical outcomes in patients on secukinumab (Cosentyx®) within a specialist psoriasis clinic: a single centre, retrospective cohort study

Journal of the European Academy of Dermatology and Venereology, 2019-02, Vol.33 (2), p.e89-e91

2019

Link zum Volltext

Verfügbarkeit prüfen

British Association of Dermatologists guidelines for use of biological interventions in psoriasis 2005

British journal of dermatology (1951), 2005-09, Vol.153 (3), p.486-497

2005

Link zum Volltext

Verfügbarkeit prüfen

Infliximab for the treatment of psoriasis in the U.K.: 9 years’ experience of infusion reactions at a single centre: Infliximab for psoriasis: 9 years’ experience of infusion reactions

British journal of dermatology (1951), 2012-08, Vol.167 (2), p.411-416

2012

Link zum Volltext

Verfügbarkeit prüfen

A retrospective cohort study of the impact of biologic therapy initiation on medical resource use and costs in patients with moderate to severe psoriasis

British journal of dermatology (1951), 2010-10, Vol.163 (4), p.807-816

2010

Link zum Volltext

Verfügbarkeit prüfen

Validity of noninvasive markers of methotrexate-induced hepatotoxicity: a retrospective cohort study

British journal of dermatology (1951), 2014-08, Vol.171 (2), p.267-273

2014

Link zum Volltext

Verfügbarkeit prüfen

Identification of loci associated with late-onset psoriasis using dense genotyping of immune-related regions

British journal of dermatology (1951), 2015-04, Vol.172 (4), p.933-939

2015

Link zum Volltext

Verfügbarkeit prüfen

Prioritizing the global research agenda in psoriasis: an International Psoriasis Council Delphi consensus exercise

British journal of dermatology (1951), 2016-01, Vol.174 (1), p.212-215

2016

Link zum Volltext

Verfügbarkeit prüfen

Demographics and disease characteristics of patients with psoriasis enrolled in the B ritish A ssociation of D ermatologists B iologic I nterventions R egister

British journal of dermatology (1951), 2015-08, Vol.173 (2), p.510-518

2015

Link zum Volltext

Verfügbarkeit prüfen

Treatment of severe, recalcitrant, chronic plaque psoriasis with fumaric acid esters: a prospective study

British journal of dermatology (1951), 2010-02, Vol.162 (2), p.427-434

2010

Link zum Volltext

Verfügbarkeit prüfen

Infliximab for the treatment of psoriasis in the U.K.: 9 years' experience of infusion reactions at a single centre

British journal of dermatology (1951), 2012-08, Vol.167 (2), p.411-416

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 103

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(94)
Mit Volltextzugriff
(103)

Publikationsform

Artikel
(95)
Berichte
(8)

Sprache

Englisch
(103)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

Dermatology
(60)
Humans
(59)
Life Sciences & Biomedicine
(56)
Science & Technology
(56)
Biological And Medical Sciences
(49)
Medical Sciences
(47)
Male
(38)
Adult
(27)
Female
(27)
Psoriasis. Parapsoriasis. Lichen
(27)
Middle Aged
(23)
Psoriasis
(23)
Psoriasis - Drug Therapy
(17)
Aged
(13)
Psoriasis - Immunology
(10)
Treatment Outcome
(10)
Dermatologic Agents - Therapeutic Use
(8)
Psoriasis - Genetics
(8)
Adolescent
(7)
Child
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

British Association of Dermatologists' guidelines for biologic interventions for psoriasis 2009

A classification of psoriasis vulgaris according to phenotype

Infliximab for severe, treatment-resistant psoriasis: a prospective, open-label study

The development of sarcoidosis on antitumour necrosis factor therapy: a paradox

Methotrexate or fumarates: which is the best oral treatment for psoriasis?: Commentaries

Screening for anxiety and depression in people with psoriasis: a cross‐sectional study in a tertiary referral setting

The quest for psoriasis susceptibility genes in the postgenome-wide association studies era: charting the road ahead: Psoriasis genetics in the post-GWAS era

Localization of endothelial proliferation and microvascular expansion in active plaque psoriasis

Demographics and disease characteristics of patients with psoriasis enrolled in the British Association of Dermatologists Biologic Interventions Register

A standardization approach to compare treatment safety and effectiveness outcomes between clinical trials and real‐world populations in psoriasis

Antinuclear antibodies associate with loss of response to antitumour necrosis factor-α therapy in psoriasis: a retrospective, observational study

The quest for psoriasis susceptibility genes in the postgenome-wide association studies era: charting the road ahead

Systemic antipsoriatic therapy may reverse endothelial dysfunction: reply from authors: Correspondence

Risks of basal cell and squamous cell carcinoma in psoriasis patients after treatment with biologic vs non‐biologic systemic therapies

Characteristics and skin cancer risk of psoriasis patients with a history of skin cancer in BADBIR

Clinical outcomes in patients on secukinumab (Cosentyx®) within a specialist psoriasis clinic: a single centre, retrospective cohort study

British Association of Dermatologists guidelines for use of biological interventions in psoriasis 2005

Infliximab for the treatment of psoriasis in the U.K.: 9 years’ experience of infusion reactions at a single centre: Infliximab for psoriasis: 9 years’ experience of infusion reactions

A retrospective cohort study of the impact of biologic therapy initiation on medical resource use and costs in patients with moderate to severe psoriasis

Validity of noninvasive markers of methotrexate-induced hepatotoxicity: a retrospective cohort study

Identification of loci associated with late-onset psoriasis using dense genotyping of immune-related regions

Prioritizing the global research agenda in psoriasis: an International Psoriasis Council Delphi consensus exercise

Demographics and disease characteristics of patients with psoriasis enrolled in the B ritish A ssociation of D ermatologists B iologic I nterventions R egister

Treatment of severe, recalcitrant, chronic plaque psoriasis with fumaric acid esters: a prospective study

Infliximab for the treatment of psoriasis in the U.K.: 9 years' experience of infusion reactions at a single centre

Suchergebnisse filtern